標(biāo)題: Titlebook: Imaging in Clinical Oncology; Athanasios D. Gouliamos,John A. Andreou,Paris A. K Book 2018Latest edition Springer International Publishing [打印本頁] 作者: Destruct 時間: 2025-3-21 16:04
書目名稱Imaging in Clinical Oncology影響因子(影響力)
書目名稱Imaging in Clinical Oncology影響因子(影響力)學(xué)科排名
書目名稱Imaging in Clinical Oncology網(wǎng)絡(luò)公開度
書目名稱Imaging in Clinical Oncology網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Imaging in Clinical Oncology被引頻次
書目名稱Imaging in Clinical Oncology被引頻次學(xué)科排名
書目名稱Imaging in Clinical Oncology年度引用
書目名稱Imaging in Clinical Oncology年度引用學(xué)科排名
書目名稱Imaging in Clinical Oncology讀者反饋
書目名稱Imaging in Clinical Oncology讀者反饋學(xué)科排名
作者: 大炮 時間: 2025-3-21 20:53 作者: 繁忙 時間: 2025-3-22 02:14
Book 2018Latest editionhe combination of radiomic data with genomic features is known as radiogenomics, and can potentially offer additional decision-making support.. This book will be of interest to clinical oncologists with regard to the diagnosis, staging, treatment and follow-up on various tumors affecting the CNS, ch作者: 世俗 時間: 2025-3-22 08:34 作者: 畢業(yè)典禮 時間: 2025-3-22 09:17 作者: Graphite 時間: 2025-3-22 16:08 作者: 甜瓜 時間: 2025-3-22 17:58
Despina M. Katsochi,Panayiotis Ch. Sandilos,Chryssa I. Paraskevopouloussification" of breast cancer, as well as the clinical applications of basic science. The crucial issue of how to optimally integrate biological markers, new technologies and new diagnostic and therapeutic approaches into clinical trials and clinical practice is addressed...Combining the contributio作者: 不能和解 時間: 2025-3-22 22:45
Michael K. Glynos,Katerina S. Malagarissification" of breast cancer, as well as the clinical applications of basic science. The crucial issue of how to optimally integrate biological markers, new technologies and new diagnostic and therapeutic approaches into clinical trials and clinical practice is addressed...Combining the contributio作者: Ruptured-Disk 時間: 2025-3-23 02:05 作者: 我的巨大 時間: 2025-3-23 09:26 作者: 修飾語 時間: 2025-3-23 12:33 作者: ARCHE 時間: 2025-3-23 15:47
Dionysis C. Voros,Theodosios C. Theodosopoulosssification" of breast cancer, as well as the clinical applications of basic science. The crucial issue of how to optimally integrate biological markers, new technologies and new diagnostic and therapeutic approaches into clinical trials and clinical practice is addressed...Combining the contributio作者: Cirrhosis 時間: 2025-3-23 20:47
Spyros D. Yarmenitisssification" of breast cancer, as well as the clinical applications of basic science. The crucial issue of how to optimally integrate biological markers, new technologies and new diagnostic and therapeutic approaches into clinical trials and clinical practice is addressed...Combining the contributio作者: 咯咯笑 時間: 2025-3-24 01:38
Dionysis C. Voros,Theodosios C. Theodosopoulosssification" of breast cancer, as well as the clinical applications of basic science. The crucial issue of how to optimally integrate biological markers, new technologies and new diagnostic and therapeutic approaches into clinical trials and clinical practice is addressed...Combining the contributio作者: indicate 時間: 2025-3-24 04:12 作者: 沒有準(zhǔn)備 時間: 2025-3-24 10:06
Vassilios Raptopoulos,Leo Tsaicrucial issue of how to optimally integrate biological markers, new technologies and new diagnostic and therapeutic approaches into clinical trials and clinical practice is addressed...Combining the contributio978-3-662-51762-8978-3-540-28266-2作者: 否決 時間: 2025-3-24 11:26 作者: 臨時抱佛腳 時間: 2025-3-24 18:50
Andreas P. Koureascrucial issue of how to optimally integrate biological markers, new technologies and new diagnostic and therapeutic approaches into clinical trials and clinical practice is addressed...Combining the contributio978-3-662-51762-8978-3-540-28266-2作者: nonsensical 時間: 2025-3-24 20:37 作者: 使厭惡 時間: 2025-3-24 23:13
Ioannis P. Boukovinascrucial issue of how to optimally integrate biological markers, new technologies and new diagnostic and therapeutic approaches into clinical trials and clinical practice is addressed...Combining the contributio978-3-662-51762-8978-3-540-28266-2作者: 吼叫 時間: 2025-3-25 05:40
Ioannis D. Papanastassiou,Nikolaos S. Demertziscrucial issue of how to optimally integrate biological markers, new technologies and new diagnostic and therapeutic approaches into clinical trials and clinical practice is addressed...Combining the contributio978-3-662-51762-8978-3-540-28266-2作者: 債務(wù) 時間: 2025-3-25 08:11 作者: nitroglycerin 時間: 2025-3-25 12:57 作者: 遷移 時間: 2025-3-25 17:35
otentially offer additional decision-making support.. This book will be of interest to clinical oncologists with regard to the diagnosis, staging, treatment and follow-up on various tumors affecting the CNS, ch978-3-030-09856-8978-3-319-68873-2作者: ARCH 時間: 2025-3-25 21:38
Molecular Imaging in Oncology: Hybrid Imaging and Personalized Therapy of Cancere chromosome tips glow brightly with appropriate color dying; they influence vulnerability, mortality, longevity, and survival. The longer the telomeres, the longer the person lives. If their length decreases, the person dies sooner. However, the utilization of telomeres in clinical practice for pat作者: microscopic 時間: 2025-3-26 02:23
Imaging Criteria for Tumor Treatment Response Evaluationervices with oncological departments. The modern imaging modalities are valuable tools for objective quantitative assessment of the result of new antineoplastic therapeutic schemes. The standardization of criteria provides common endpoints for clinical trials, permits comparisons between different s作者: 名字 時間: 2025-3-26 06:28
Interventional Radiology in Oncologytion or core biopsy under imaging guidance. IR techniques are worldwide used for palliative treatment: venous, biliary, esophageal, duodenal, enteric, ureteric, or airway obstructions due to malignant compression or infiltration are now being treated almost exclusively by percutaneous or transoral s作者: MEET 時間: 2025-3-26 10:03
Introduction to Radiogenomicsevel. In oncology, this has led to better understanding of tumor genesis and gene expression signatures, involving anywhere from a few dozens to hundreds of genes. This has in turn improved classification and subclassification of tumors and prediction of treatment response [1]. In this respect, gene作者: 縮短 時間: 2025-3-26 15:22
Introduction to Soft Tissue Sarcomasent degrees of malignancy, biological behavior, and specific therapeutic options. The incidence of STS, excluding gastrointestinal stromal tumor, is relatively low (4–5/100,000/year in Europe) [1], whereas bone sarcomas account for 0.2% of malignant tumors registered in the Eurocare database [2]. Ac作者: 斑駁 時間: 2025-3-26 19:04
Introduction to Bone Sarcomas, with soft tissue sarcomas being around 80% off all sarcomas. Bone sarcomas are seen more often in childhood (except chondrosarcomas), while soft tissue sarcomas predominate in the elderly. Since they have distinct features, they will be discussed separately (NCCN Guidelines (2012) Bone cancer. Ver作者: LIEN 時間: 2025-3-27 00:46 作者: Ingratiate 時間: 2025-3-27 03:03
Conventional Radiology of Bone and Soft Tissue Tumorsction of bone tumors. The most important clinical aspect is patient’s age. The specific radiographic appearances that enable both differential shortening and more accurate tumor characterization are tumor location, lesion margins and zone of transition, periosteal reaction, radiographic opacity and 作者: Supplement 時間: 2025-3-27 06:15 作者: GRUEL 時間: 2025-3-27 11:58
Positron Emission Tomography in Bone and Soft Tissue Tumorsional and anatomical information. The combination of PET with CT has been established as an imaging modality and is currently widely used in oncology. Bone and soft tissue tumors, as of course the majority of tumors, are characterized of multiple metabolic and molecular alterations, which allow imag作者: Deceit 時間: 2025-3-27 17:30
Clinical Implications of Retroperitoneal Sarcomasr, desmoids, functioning and nonfunctioning adrenal masses, renal tumor, pancreatic tumor, and gastrointestinal stromal tumor, should be considered. If visceral invasion is present, the differential should include tumors of these organs, and endoscopy with biopsy, if feasible, to evaluate for intral作者: ANTI 時間: 2025-3-27 19:20 作者: 不能根除 時間: 2025-3-27 23:42 作者: Collar 時間: 2025-3-28 03:57 作者: ingenue 時間: 2025-3-28 09:39
George N. Sfakianakisa dream for the future, but the main goal of current research...This book provides an overview of the most recent techniques, agents and approaches for breast cancer that contribute to the individualization of treatment. Current biomedical research focuses on facilitating the transfer of molecular b作者: Gnrh670 時間: 2025-3-28 12:33 作者: 長矛 時間: 2025-3-28 15:36 作者: 昆蟲 時間: 2025-3-28 18:52
Michael K. Glynos,Katerina S. Malagaria dream for the future, but the main goal of current research...This book provides an overview of the most recent techniques, agents and approaches for breast cancer that contribute to the individualization of treatment. Current biomedical research focuses on facilitating the transfer of molecular b作者: insincerity 時間: 2025-3-29 02:43 作者: 一瞥 時間: 2025-3-29 03:15
Vassilios Raptopoulos,Leo Tsai-depth information on diagnosis, therapy and the entire clin.Molecular-based medicine is taking center stage due to the increasing knowledge of breast cancer molecular biology. Treatment tailoring is no longer a dream for the future, but the main goal of current research...This book provides an over作者: 排名真古怪 時間: 2025-3-29 07:32
-depth information on diagnosis, therapy and the entire clin.Molecular-based medicine is taking center stage due to the increasing knowledge of breast cancer molecular biology. Treatment tailoring is no longer a dream for the future, but the main goal of current research...This book provides an over作者: CHOP 時間: 2025-3-29 12:14 作者: Synapse 時間: 2025-3-29 16:34
Ioannis D. Papanastassiou,Nikolaos S. Demertzisa dream for the future, but the main goal of current research...This book provides an overview of the most recent techniques, agents and approaches for breast cancer that contribute to the individualization of treatment. Current biomedical research focuses on facilitating the transfer of molecular b作者: ingenue 時間: 2025-3-29 22:14 作者: BRAWL 時間: 2025-3-30 03:09 作者: 改變立場 時間: 2025-3-30 07:49
Andreas P. Koureas-depth information on diagnosis, therapy and the entire clin.Molecular-based medicine is taking center stage due to the increasing knowledge of breast cancer molecular biology. Treatment tailoring is no longer a dream for the future, but the main goal of current research...This book provides an over作者: 徹底檢查 時間: 2025-3-30 09:58 作者: 上流社會 時間: 2025-3-30 15:26 作者: 身心疲憊 時間: 2025-3-30 18:25 作者: synovium 時間: 2025-3-30 21:02
